期刊
PHARMACOGENOMICS
卷 16, 期 2, 页码 97-99出版社
FUTURE MEDICINE LTD
DOI: 10.2217/pgs.14.176
关键词
HER2; PIK3CA; mTOR; targeted therapy; uterine serous carcinoma
资金
- NATIONAL CANCER INSTITUTE [P30CA016359, R01CA154460] Funding Source: NIH RePORTER
- NCI NIH HHS [R01CA154460-01A1, CA-16359] Funding Source: Medline